Ambulatory distance, time, episodes, resting time, latency toward center of the chamber, number of center zone entries, and jump counts were analyzed using activity chamber after 10 days of treatment with vehicle‐TAT or P110 at 3 mg/kg/day in G93A SOD1 mice. Grip strength test was carried out to assess the on muscular degeneration after 24 days of treatment.